Gene expression profile of renal cell carcinoma clear cell type

International Braz J Urol

Volumn 36, Issue 4, 2010, Pages 410-418

  Dall'Oglio, Marcos F ^a   Coelho, Rafael F ^a   Leite, Katia R M ^a   Sousa Canavez, Juliana M ^b   Oliveira, Paulo S L ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Genoa Biotechnology   (Brazil)

Author keywords

Carcinoma, renal cell; Gene expression profiling; Interleukin 8, heat shock protein; Microarray analysis; Neoplasm metastasis; Oncogenes

Indexed keywords

HEAT SHOCK PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; KIDNEY NEOPLASMS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 78049460646     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382010000400004     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-49.
3. Uchida K, Miyao N, Masumori N, Takahashi A, Oda T, Yanase M, et al.: Recurrence of renal cell carcinoma more than 5 years after nephrectomy. Int J Urol. 2002; 9: 19-23.
4. Levy DA, Slaton JW, Swanson DA, Dinney CP: Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998; 159: 1163-7.
5. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al.: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002; 347: 1999-2009.
6. Yang XJ, Sugimura J, Schafernak KT, Tretiakova MS, Han M, Vogelzang NJ, et al.: Classification of renal neoplasms based on molecular signatures. J Urol. 2006; 175: 2302-6.
7. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, et al.: Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 2005; 11: 5730-9.
8. Liou LS, Shi T, Duan ZH, Sadhukhan P, Der SD, Novick AA, et al.: Microarray gene expression profiling and analysis in renal cell carcinoma. BMC Urol. 2004; 4: 9.
9. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, et al.: Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res. 2005; 11: 5128-39.
10. Smyth GK: Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, (ed.), Bioinformatics and computational biology solutions using R and bioconductor. New York, Springer. 2005; pp. 397-420.
11. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-8.
12. Dall'Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M: Impact of clinicopathological parameters in patients treated for renal cell carcinoma. J Urol. 2007; 177: 1687-91.
13. Yin-Goen Q, Dale J, Yang WL, Phan J, Moffitt R, Petros JA, et al.: Advances in molecular classification of renal neoplasms. Histol Histopathol. 2006; 21: 325-39.
14. Langner C, Ratschek M, Rehak P, Tsybrovskyy O, Zigeuner R: The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology? BJU Int. 2005; 95: 310-4.
15. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, et al.: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007; 356: 115-24.
16. Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, et al.: Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol. 2006; 29: 799-827.
17. Staehler M, Rohrmann K, Haseke N, Stief CG, Siebels M: Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets. 2005; 6: 835-46.
18. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, et al.: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet. 1994; 3: 2169-73.
19. Caldwell MC, Hough C, Fürer S, Linehan WM, Morin PJ, Gorospe M: Serial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFalpha cytotoxicity. Oncogene. 2002; 21: 929-36.
20. Seliger B, Lichtenfels R, Kellner R: Detection of renal cell carcinoma-associated markers via proteome-and other 'ome'-based analyses. Brief Funct Genomic Proteomic. 2003; 2: 194-212.
21. Santarosa M, Favaro D, Quaia M, Galligioni E: Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients. Eur J Cancer. 1997; 33: 873-7.
22. Lichtenfels R, Kellner R, Bukur J, Beck J, Brenner W, Ackermann A, et al.: Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics. 2002; 2: 561-70.
23. Javid B, MacAry PA, Lehner PJ: Structure and function: heat shock proteins and adaptive immunity. J Immunol. 2007; 179: 2035-40.
24. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al.: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992; 258: 1798-801.
25. Yoshida T, Matsumoto E, Hanamura N, Kalembeyi I, Katsuta K, Ishihara A, et al.: Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J Pathol. 1997; 182: 421-8.